权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Epigenetic regulation of gene expression by the exoribonuclease pacman

核糖核酸外切酶 pacman 对基因表达的表观遗传调控

基本信息

批准号：
BB/I021345/1
负责人：
Sarah Newbury
金额：
$ 56.98万
依托单位：
University of Sussex
依托单位国家：
英国
项目类别：
Research Grant
财政年份：
2011
资助国家：
英国
起止时间：
2011 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=BB%2FI021345%2F1
关键词：
Epigenetic regulation gene expression exoribonuclease

项目摘要

Development of an organism from egg to adult requires sets of genes to be switched on and off at particular times and in the correct order. If genes are not switched off when necessary, cells can continue to multiply in an uncontrolled way leading to cancer. As well as being important in cancer, gene regulation is crucial in controlling the balance between stem cell self-renewal and pathways to cell specialisation which are required to form the particular cells and tissues in the body. Since stem cells have a vast potential in regenerative medicine for the replacement of defective tissue, the understanding of gene control is crucial for harnessing the potential of these cells. Therefore studying the mechanisms whereby genes are switched off (as well as on) is vitally important for providing basic knowledge that has potential to lead to novel therapeutics. Using the fruit fly Drosophila as a model organism, we have recently discovered that an enzyme named Pacman is involved in the growth and differentiation of imaginal discs, which form adult structures such as wings and legs. Imaginal discs are similar to stem cells in that they carry the information to build the adult tissue. We have shown that Pacman normally affects the production of a protein called Simjang (Korean for 'strong heart') which in turn controls a gene silencing complex (the NuRD complex) which shuts down parts of the chromosome, preventing genes from being turned on. This gene silencing complex is important because it is known to be involved in many critical cellular events including tissue regeneration, formation of blood cells, ageing and spread of cancer cells. This is the first time that an enzyme involved in degradation of messenger RNA has been shown to be directly affecting a gene silencing complex. The aim of this project is to understand how the Pacman uses Simjang to control particular sets of genes involved in growth and differentiation. Our hypothesis is that, in normal cells, simjang messenger RNA is somehow 'tagged' for destruction so that not much of Simjang protein is made. This means that there is not enough Simjang to turn on the gene silencing complexes. These gene silencing complexes, when activated, normally act as 'brakes' to prevent growth and differentiation of the wing disc. Therefore when the brake is not pressed by Simjang, these genes are not turned on, allowing normal growth and development of the tissue. When the pacman gene is mutated, there is no (or little) degradation of simjang RNA, resulting in more Simjang protein, which turns on the gene silencing complexes (i.e. presses the brake) therefore switching on genes that prevent tissue growth and development. In this project we aim to test this hypothesis, find out the details of this gene control pathway and identify the genes which act as brakes to prevent growth and development. The mechanism of gene regulation which forms the basis of this proposal is entirely novel; as yet no research group has found this link between RNA degradation and gene silencing. Since all the proteins involved are similar in Drosophila and humans the new 'control module' we have discovered is likely to be relevant to gene regulation in humans. Since Pacman is known to be important in other important cellular events such as wound healing, migration of cell sheets, and male fertility, this work may also shed light on the molecular mechanisms of these processes in other tissues. Therefore the insights we gain during this project may help us to improve treatment for cancer and other diseases and also help us to understand the ways that tissues grow and develop. This project will therefore provide valuable insights into a new method of gene regulation which can be used in the development of new therapeutics.

生物体从卵到成虫的发育需要一组基因在特定的时间以正确的顺序打开和关闭。如果基因在必要时没有关闭，细胞可以继续以不受控制的方式繁殖，导致癌症。除了在癌症中很重要外，基因调控在控制干细胞自我更新和细胞特化途径之间的平衡方面也至关重要，细胞特化途径是形成体内特定细胞和组织所必需的。由于干细胞在再生医学中具有替代缺陷组织的巨大潜力，因此了解基因控制对于利用这些细胞的潜力至关重要。因此，研究基因关闭（以及打开）的机制对于提供有可能导致新疗法的基础知识至关重要。以果蝇为模式生物，我们最近发现一种名为Pacman的酶参与了成虫盘的生长和分化，成虫盘形成了翅膀和腿等成虫结构。想象中的椎间盘与干细胞相似，因为它们携带着构建成人组织的信息。我们已经证明，吃豆人通常会影响一种名为Simjang的蛋白质的产生（韩语中的“强壮的心脏”），反过来控制基因沉默复合体这种基因沉默复合物很重要，因为已知它参与许多关键的细胞事件，包括组织再生，血细胞的形成，衰老和癌细胞的扩散。这是第一次证明参与信使RNA降解的酶直接影响基因沉默复合体。该项目的目的是了解Pacman如何使用Simjang来控制参与生长和分化的特定基因组。我们的假设是，在正常细胞中，Simjang信使RNA以某种方式被“标记”为破坏，因此没有太多的Simjang蛋白质。这意味着没有足够的Simjang来打开基因沉默复合物。这些基因沉默复合物，当被激活时，通常作为“刹车”，以防止翼盘的生长和分化。因此，当刹车没有被Simjang按下时，这些基因不会被打开，允许组织正常生长和发育。当pacman基因突变时，没有（或很少）Simjang RNA降解，导致更多的Simjang蛋白，这打开了基因沉默复合物（即按下刹车），因此打开了阻止组织生长和发育的基因。在这个项目中，我们的目标是测试这一假设，找出这个基因控制途径的细节，并确定基因作为刹车，以防止生长和发育。构成这一提议基础的基因调控机制是全新的;迄今为止，还没有研究小组发现RNA降解和基因沉默之间的这种联系。由于果蝇和人类的所有相关蛋白质都很相似，我们发现的新“控制模块”很可能与人类的基因调控有关。由于已知Pacman在其他重要的细胞事件中很重要，如伤口愈合，细胞片迁移和男性生育力，这项工作也可能揭示其他组织中这些过程的分子机制。因此，我们在这个项目中获得的见解可能有助于我们改善癌症和其他疾病的治疗，也有助于我们了解组织生长和发育的方式。因此，该项目将为基因调控的新方法提供有价值的见解，该方法可用于开发新的治疗方法。

项目成果

期刊论文数量（10）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.

DOI：
10.1038/bjc.2012.525
发表时间：
2012-12-04
期刊：
BRITISH JOURNAL OF CANCER
影响因子：
8.8
作者：
Jones, C. I.;Zabolotskaya, M. V.;King, A. J.;Stewart, H. J. S.;Horne, G. A.;Chevassut, T. J.;Newbury, S. F.
通讯作者：
Newbury, S. F.

XRN 5'→3' exoribonucleases: structure, mechanisms and functions.

XRN 5'→3'驱虫核酸酶：结构，机制和功能。

DOI：
10.1016/j.bbagrm.2013.03.005
发表时间：
2013-06
期刊：
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子：
4.7
作者：
Nagarajan, Vinay K.;Jones, Christopher I.;Newbury, Sarah F.;Green, Pamela J.
通讯作者：
Green, Pamela J.

RNA-seq reveals post-transcriptional regulation of Drosophila insulin-like peptide dilp8 and the neuropeptide-like precursor Nplp2 by the exoribonuclease Pacman/XRN1.